# Lactobacillus reuteri — Your Most Targeted Natural Counter to Fusobacterium nucleatum
Not all probiotics are equally relevant to **Fusobacterium nucleatum**.
**Limosilactobacillus reuteri** stands out because its anti-**Fn** activity is more specific and more mechanistically developed than most general probiotic blends.
### Why this probiotic stands apart
A 2025 study showed that **L. reuteri** can physically **coaggregate** with **Fusobacterium nucleatum**.
In practical terms, that means the organisms bind to each other.
That changes the biofilm ecology in several useful ways:
* **Fn** biofilm burden falls sharply
* **Fn** loses some of its ability to organise pathogenic biofilm structure
* **Fn** lipopolysaccharide exposure may be partly neutralised at the local biofilm level
The same work also reported benefit against **Porphyromonas gingivalis**.
That matters because these organisms often behave as partners inside periodontal disease.
### Why yoghurt may make more sense than capsules
This is the practical detail that matters most.
A standard capsule gives a fixed dose of organisms in a shelf-stable format.
That can still be useful.
A properly fermented **L. reuteri yoghurt** is different.
It delivers:
* much higher live bacterial counts
* repeated exposure in a food matrix
* fermentation byproducts that may add ecological pressure against pathogens
* better oral and gastrointestinal contact time
That is why the yoghurt approach is often more biologically compelling than a capsule-only approach.
The goal is not a one-off probiotic hit.
The goal is consistent colonisation pressure over time.
### Practical interpretation
If the target is **oral and gut ecological displacement** of **Fusobacterium nucleatum**, high-viability food delivery may be the stronger model.
That does not make capsules useless.
It does suggest that preparation method matters.
A full companion page on **L. reuteri yoghurt**, strain choice, fermentation, and oncology-specific practical notes will be added next and linked here.
{% hint style="warning" %}
Probiotic use may need extra caution in some treatment settings, especially with severe neutropenia, central lines, or major mucosal injury.
Review it in context.
{% endhint %}
### Key References
Limosilactobacillus reuteri–Fusobacterium nucleatum interactions: coaggregation reduces biofilm Fn by 1000-fold\
Chemical characterization of an antimicrobial substance produced by Lactobacillus reuteri\
Lactobacillus reuteri AN417 cell-free culture supernatant as a novel antibacterial agent against periodontal pathogens\
Probiotic effects of orally administered Lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis\
Effect of yoghurt containing polydextrose, Lactobacillus acidophilus and Bifidobacterium lactis on severity of constipation in patients with gastrointestinal disease\
---
# Agent Instructions: Querying This Documentation
If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.
Perform an HTTP GET request on the current page URL with the `ask` query parameter:
```
GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/pathogens/microbial-pathogens/fusobacterium-nucleatum-fn-a-powerful-oncobacterium/lactobacillus-reuteri-your-most-targeted-natural-counter-to-fusobacterium-nucleatum.md?ask=
```
The question should be specific, self-contained, and written in natural language.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.
Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.